Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiology of Alzheimer’s Disease
Brandon C. Yarns, Kelsey A. Holiday, David M. Carlson, et al.
Psychiatric Clinics of North America (2022) Vol. 45, Iss. 4, pp. 663-676
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Alzheimer’s Disease—Biochemical and Psychological Background for Diagnosis and Treatment
Bocwinska-Kiluk Beata, Wojciech Jelski, Johannes Kornhuber, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1059-1059
Open Access | Times Cited: 45
Understanding neuropsychiatric symptoms in Alzheimer’s disease: challenges and advances in diagnosis and treatment
Andrew Pless, Destany Ware, Shalini Saggu, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 43
Alzheimer's disease pathophysiology in the Retina
Bhakta Prasad Gaire, Yosef Koronyo, Dieu‐Trang Fuchs, et al.
Progress in Retinal and Eye Research (2024) Vol. 101, pp. 101273-101273
Open Access | Times Cited: 22
Altered ubiquitin signaling induces Alzheimer’s disease-like hallmarks in a three-dimensional human neural cell culture model
Inbal Maniv, Mahasen Sarji, Anwar Bdarneh, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Akt signaling pathway: a potential therapy for Alzheimer’s disease through glycogen synthase kinase 3 beta inhibition
Joshua Limantoro, Bryan Gervais de Liyis, Jane Carissa Sutedja
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2023) Vol. 59, Iss. 1
Open Access | Times Cited: 22
Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights
Kushagra Nagori, Kartik T. Nakhate, Krishna Yadav, et al.
Future Pharmacology (2023) Vol. 3, Iss. 4, pp. 877-907
Open Access | Times Cited: 19
From Inhalation to Neurodegeneration: Air Pollution as a Modifiable Risk Factor for Alzheimer’s Disease
Jordi Olloquequi, Roberto Díaz‐Peña, Ester Verdaguer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6928-6928
Open Access | Times Cited: 5
In vitro and in vivo Investigations of 4-Substituted 2-Phenylquinazoline derivatives as multipotent ligands for the treatment of Alzheimer’s disease
Vijay Kumar, Kailash Jangid, Vishal Kumar, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108126-108126
Closed Access
Unlocking the Vitamin Puzzle: Investigating Levels in People With Alzheimer's Disease Versus Healthy Controls Through Systematic Review and Network Meta‐Analysis
Steven Marwaha, Rachna Agarwal, Manjari Tripathi, et al.
Journal of Human Nutrition and Dietetics (2025) Vol. 38, Iss. 1
Closed Access
Inhibition of the Transforming Growth Factor‐β Signaling Pathway Confers Neuroprotective Effects on Beta‐Amyloid‐Induced Direct Neurotoxicity and Microglia‐Mediated Neuroinflammation
Shao Qin Tiong, Raxshanaa N Mohgan, Jia Yee Quek, et al.
Neurology Research International (2025) Vol. 2025, Iss. 1
Open Access
Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer’s disease
Miyah R. Davis, Edward Robinson, Yosef Koronyo, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
Future Perspectives of NMDAR in CNS Disorders
Toni Capó, Joan Biel Rebassa, Iu Raïch, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 877-877
Open Access
Beyond expectations: investigating nilotinib’s potential in attenuating neurodegeneration in alzheimer’s disease
Darcy Tocci, Mark A. Fogel, Vanya Gupta, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access
Oroxylum indicum (L.) Leaf Extract Attenuates β-Amyloid-Induced Neurotoxicity in SH-SY5Y Cells
Nut Palachai, Benjaporn Buranrat, Parinya Noisa, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2917-2917
Open Access
Unveiling the Protective Roles of Melatonin on Glial Cells in the Battle Against Alzheimer’s Disease—Insights from In Vivo and In Vitro Studies
Nopdanai Sirimaharaj, Kitti Thiankhaw, Nipon Chattipakorn, et al.
Molecular Neurobiology (2025)
Closed Access
Extracellular vesicles from hiPSC-derived NSCs protect human neurons against Aβ-42 oligomers induced neurodegeneration, mitochondrial dysfunction and tau phosphorylation
Shama Rao, Leelavathi N. Madhu, Roshni Sara Babu, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Development of Activity Rules and Chemical Fragment Design for In Silico Discovery of AChE and BACE1 Dual Inhibitors against Alzheimer’s Disease
Le-Quang Bao, Daniel Baecker, Do Thi Mai Dung, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3588-3588
Open Access | Times Cited: 10
Potential Application of MicroRNAs and Some Other Molecular Biomarkers in Alzheimer’s Disease
Olga Paprzycka, Jan Wieczorek, Ilona Nowak, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5066-5084
Open Access | Times Cited: 3
Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's disease
Miyah R. Davis, Edward Robinson, Yosef Koronyo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases
Efthalia Angelopoulou, Efstratios‐Stylianos Pyrgelis, Chetana Ahire, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1257-1257
Open Access | Times Cited: 6
RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease
Pavel Strnad, Javier San Martín
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 7, pp. 571-581
Closed Access | Times Cited: 5
Mapping trends and hotspots of mitochondrial dysfunction in Alzheimer’s disease from 2013 to 2022: a bibliometric analysis of global research
Guo Wang, L. Hassan, Yu-hao Chu, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 4
MGST3 regulates BACE1 protein translation and amyloidogenesis by controlling the RGS4-mediated AKT signaling pathway
Yalan Pu, Jie Yang, Qiuling Pan, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 8, pp. 107530-107530
Open Access | Times Cited: 1
Amyloid deposition and its association with depressive symptoms and cognitive functions in late-life depression: A longitudinal study using amyloid- β PET images and neuropsychological measurements
Kiwon Kim, Yoo Jin Jang, Jeong-Hyeon Shin, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Bio-AD: A Transfer Learning Approach for Diagnosis of Alzheimer’s Diseases in MRI Scans
Mian Muhammad Sadiq Fareed, Gulnaz Ahmed, Shahid Zikria, et al.
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top